Pharma Insight ApS Financials, key figures and credit report
Gross profit 342.2 kDKK FY 2025 +147.2% vs 2024
EBIT 342.2 kDKK FY 2025 +147.2% vs 2024
Net debt - 340.1 kDKK FY 2025 -110.9% vs 2024
Quick ratio 3.4 FY 2025 -0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 725.06 | -27.01 | -17.12 | 138.46 | 342.21 |
| Employee benefit expenses | - 661.50 | -1.25 | |||
| EBIT | 63.56 | -28.26 | -17.12 | 138.46 | 342.21 |
| Other financial income | 0.95 | 2.41 | 0.18 | 0.48 | 0.03 |
| Other financial expenses | -1.94 | -0.76 | -1.92 | -1.01 | -1.79 |
| Pre-tax profit | 62.57 | -26.61 | -18.86 | 137.92 | 340.44 |
| Income taxes | -14.63 | -20.17 | -75.28 | ||
| Net earnings | 47.94 | -26.61 | -18.86 | 117.75 | 265.16 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 16.00 | 82.91 | |||
| Current amounts owed by group member comp. | 77.92 | 82.82 | |||
| Current other receivables | 3.67 | 3.24 | 3.09 | 1.56 | |
| Short term receivables total | 81.59 | 86.06 | 3.09 | 16.00 | 84.47 |
| Cash and bank deposits | 327.44 | 69.75 | 44.22 | 189.85 | 399.67 |
| Cash and cash equivalents | 327.44 | 69.75 | 44.22 | 189.85 | 399.67 |
| Balance sheet total (assets) | 409.03 | 155.81 | 47.31 | 205.85 | 484.13 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 100.00 | 100.00 | 70.00 | 200.00 | |
| Retained earnings | 84.88 | 32.82 | 6.20 | -82.66 | - 164.91 |
| Profit of the financial year | 47.94 | -26.61 | -18.86 | 117.75 | 265.16 |
| Shareholders equity total | 272.82 | 146.20 | 27.35 | 145.09 | 340.25 |
| Non-current liabilities total | |||||
| Current trade creditors | 10.00 | 7.50 | 7.50 | 8.50 | 9.00 |
| Current owed to participating | 22.88 | 9.87 | 5.36 | ||
| Current owed to group member | 10.63 | 18.75 | 54.23 | ||
| Short-term deferred tax liabilities | 14.63 | 20.17 | 75.28 | ||
| Other non-interest bearing current liabilities | 88.70 | 2.11 | 1.84 | 3.47 | |
| Current liabilities total | 136.21 | 9.61 | 19.97 | 60.76 | 143.88 |
| Balance sheet total (liabilities) | 409.03 | 155.81 | 47.31 | 205.85 | 484.13 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated